Descriptors
Documents disponibles dans cette catégorie (8)
Add the result to your basket Make a suggestion Refine your search Apply to external sources
Extend search on down-posting(s)
BioMed research international / Abdelali Haoudi / New York [United States] : Hindawi Publishing Corporation
[serial] See available issues Search in serial BioMed research international = Biomed Res Int [printed text] / Abdelali Haoudi, . - New York [United States] : Hindawi Publishing Corporation.
ISSN : 2314-6133
IF: http://www.bioxbio.com/if/html/BIOMED-RES-INT.html
SJR: http://www.scimagojr.com/journalsearch.php?q=21100230018&tip=sid
Indexed in:
Index medicus: v2013, 2013-
MEDLINE: v2013, 2013-
PubMed: v2013, 2013-
PMC
Languages : English (eng)
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Biomedical Research ; Biotechnology ; International Cooperation ; Peer Review ; PeriodicalsAbstract: BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in several areas of life sciences. The journal’s Editorial Board is divided into the 55 subject areas included within the journal’s scope.
BioMed Research International was founded in 2001 by Professor Abdelali Haoudi who served as the Editor-in-Chief of the journal between 2001 and 2008.
The most recent Impact Factor for BioMed Research International is 2.134 according to the 2015 Journal Citation Reports released by Thomson Reuters in 2016.
BioMed Research International currently has an acceptance rate of 28%. The average time between submission and final decision is 61 days and the average time between acceptance and publication is 37 days.Link for e-copy: https://www.hindawi.com/journals/bmri/ Format of e-copy: Website Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4030 Hearing impairment : an invisible disability / Jun'ichi Suzuki / New York ; Berlin ; Tokyo : Springer (2004)
Hearing impairment : an invisible disability : how you can live with a hearing impairment [printed text] / Jun'ichi Suzuki, Author ; Takeo Kobayashi, Author ; Keijiråo Koga . - New York ; Berlin ; Tokyo : Springer, 2004 . - XXVI, 580 p. : 220 illus.
ISBN : 978-4-431-22326-9 : 68,17 €
Languages : English (eng)
Descriptors: Classification
WV 270 Audiology. Hearing. Hearing disorders. Deafness
Indexation
Cross-Cultural Comparison ; Deafness ; Hearing Aids ; Hearing Loss ; International Cooperation ; Persons With Hearing Impairments ; psychology [Subheading] ; Rehabilitation of Hearing Impaired ; Social SupportAbstract: Hearing Impairment - An Invisible Disability is the first work of its kind to comprehensively cover all aspects of hearing impairment. It covers the following categories through more than 100 contributions from all over the world to constitute an encyclopedia of hearing impairment:
- Hearing Basics: What does hearing impairment mean? Its causes and effects are explained through many real-world examples.
- Children: Childhood is a time when hearing impairment often begins, so proper treatment at an early stage can help alleviate difficulties and allow for as normal a life as possible. Many case studies from both the developed and developing parts of the world, including Indonesia and Latin America in the latter category, are provided to aid comprehension.
- Hearing Aids: Through newly emerging technology and with the help of electronics companies, new and affordable hearing aids are being developed and marketed. The authors take a closer look at this burgeoning field.
- Medical Aspects: Medical treatment of hearing impairment has recently shown remarkable change, manifested in improved techniques and applications all over the world. Although mainly of relevance to researchers and practicing physicians, the clear explanation of the medical and technical terminology is likely to be of interest to all concerned with the future of hearing impairment.
- Social and International Help: With a wealth of assistance from individuals, NGOs, and international organizations specifically tailored to help the hearing impaired, those in need of guidance can gain confidence from the knowledge that substantial support is available to help them pursue a full and varied life.Contents note: I. Hearing Basics. -- II. Children. -- III. Hearing Aids. -- IV. Medical Aspects. -- V. Social and International Help. Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=61 Hold
Place a hold on this item
Copies(1)
Barcode Call number Media type Location Section Status 10273-00443 WV270/SUZ Book KCE Library (10.124) Available Horizon scanning for pharmaceuticals / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
Horizon scanning for pharmaceuticals : proposal for the BeNeLuxA collaboration [printed text] / Isabelle Lepage-Nefkens , Author ; Karla Douw, Author ; Gertjan Mantjes, Author ; Gimon de Graaf, Author ; Roos Leroy , Author ; Irina Cleemput , Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2017 . - 162 p. : ill., ; A4. - (KCE Reports. Health Services Research (HSR); 283C) .
ISSN : D/2017/10.273/15 : € 0,00
Study 2015-57
Languages : English (eng)
Descriptors: Classification
QV 736 Drug industry. Economics of pharmacy. Advertising
Indexation
2015-57 ; Costs and Cost Analysis ; Economics, Pharmaceutical ; Europe ; Health Policy ; Information dissemination ; International Cooperation ; Policy Making ; Program Development ; R283 ; Technology Assessment, BiomedicalContents note: TABLE OF CONTENTS 1 -- LIST OF FIGURES 5 -- LIST OF TABLES 6 -- LIST OF ABBREVIATIONS 8 -- SCIENTIFIC REPORT 12 -- 1 SCOPE AND OBJECTIVES OF THE STUDY 12 -- 2 WHAT IS A HORIZON SCANNING SYSTEM? 13 -- 3 METHODS 17 -- 3.1 INTERNATIONAL COMPARISON 17 -- 3.1.1 Data collection 17 -- 3.1.2 Data analysis 18 -- 3.2 DEVELOPMENT OF A PROPOSAL FOR A JOINT HSS 18 -- 3.3 FEASIBILITY STUDY 19 -- 3.3.1 Selection of products 19 -- 3.3.2 Development of a database template for data aggregation 19 -- 3.3.3 Data collection on the products 19 -- 3.3.4 Setting up company pipeline meetings 20 -- 3.3.5 Setting up meetings with medical societies 20 -- 3.3.6 Estimation of potential high financial impact 20 -- 4 INTERNATIONAL COMPARISON 21 -- 4.1 BRIEF DESCRIPTION OF SELECTED HS SYSTEMS 21 -- 4.2 GOALS OF THE HSS 24 -- 4.3 HS UNIT AND CUSTOMER 26 -- 4.4 TIME HORIZON 27 -- 4.5 IDENTIFICATION 30 -- 4.6 FILTRATION 33 -- 4.7 PRIORITIZATION 35 -- 4.8 EARLY ASSESSMENT. 39 -- 4.9 INVOLVEMENT OF EXPERTS AND OTHER STAKEHOLDERS 44 -- 4.10 DISSEMINATION 44 -- 4.11 UPDATING INFORMATION 45 -- 4.12 EVALUATION OF HS SYSTEMS. 45 -- 4.13 CONCLUSION 46 -- 5 PROPOSAL FOR A JOINT BENELUXA HORIZON SCANNING SYSTEM 47 -- 5.1 OBJECTIVE OF THE COLLABORATIVE HSS 48 -- 5.2 HS PROCESS 48 -- 5.3 ORGANIZATION OF A JOINT HSS 51 -- 5.4 SCOPE 51 -- 5.5 TIME HORIZON 52 -- 5.6 IDENTIFICATION 52 -- 5.6.1 Identification through pre-set list of sources 52 -- 5.6.2 (Semi-)Automation of the scanning process 53 -- 5.7 INTERNATIONAL FILTRATION 54 -- 5.8 DATA COLLECTION 55 -- 5.8.1 Collection of minimal information to allow assessment of potential impact 55 -- 5.8.2 Collection of extended information on pharmaceuticals with potential high impact 56 -- 5.8.3 Company pipeline meetings 57 -- 5.8.4 Country-specific data collection 58 -- 5.8.5 Database 59 -- 5.9 DISSEMINATION 60 -- 5.10 SUMMARY OF PROPOSED METHODOLOGY OF COLLABORATIVE HSS 60 -- 5.11 RECOMMENDATION FOR COUNTRY-SPECIFIC PRIORITIZATION 62 -- 5.11.1 Step 1: Create filtration and prioritization criteria 62 -- 5.11.2 Step 2: Assign teams for prioritization 65 -- 5.11.3 Step 3: Filter relevant products 65 -- 5.11.4 Step 4: Choose a method for priority-setting and perform prioritization 65 -- 5.12 PRIORITIZATION FOR “JOINT ACTIVITIES” 67 -- 5.13 ESTABLISHMENT OF THE COLLABORATIVE SYSTEM 67 -- 5.13.1 Start-up investment 67 -- 5.13.2 Annual budget 68 -- 5.13.3 Pilot phase 68 -- 6 FEASIBILITY OF INVOLVING COMPANIES AND CLINICAL EXPERTS IN BELGIUM 69 -- 6.1 RESULTS 69 -- 6.1.1 Selection of products 69 -- 6.1.2 Development of a database template for data aggregation 71 -- 6.1.3 Gathering information on the products. 71 -- 6.1.4 Company pipeline meetings 71 -- 6.1.5 Meeting with medical societies 73 -- 6.1.6 Estimation of potential high financial impact 74 -- 6.2 LESSONS LEARNT FROM THE FEASIBILITY STUDY 76 -- 7 GENERAL DISCUSSION AND CONCLUSION 78 -- 7.1 BENEFITS AND PREREQUISITES OF A PERFORMANT JOINT HSS 78 -- 7.2 WIDER SOCIETAL BENEFITS OF A JOINT HSS 79 -- 7.3 FLEXIBLE STEP-WISE IMPLEMENTATION OF A JOINT HSS 79 -- APPENDICES 80 -- APPENDIX 1. COUNTRY DESCRIPTIONS 80 -- APPENDIX 1.1. DUTCH HORIZON SCANNING SYSTEM 80 -- APPENDIX 1.2. ASSOCIATION OF LOCAL AUTHORITIES AND REGIONS (SKL) – SWEDEN 88 -- APPENDIX 1.3. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY (AHRQ) – UNITED STATES 93 -- APPENDIX 1.4. ITALIAN HORIZON SCANNING PROJECT (IHSP) - ITALY 102 -- APPENDIX 1.5. HORIZON SCANNING RESEARCH & INTELLIGENCE CENTRE (NIHR HSRIC) – ENGLAND/WALES 108 -- APPENDIX 1.6. UK MEDICINES INFORMATION (UKMI) – UNITED KINGDOM 115 -- APPENDIX 1.7. SCOTTISH MEDICINES CONSORTIUM (SMC) – SCOTLAND 121 -- APPENDIX 1.8. ALL WALES MEDICINES STRATEGY GROUP (AWMSG) – WALES 126 -- APPENDIX 2. SCANNING AND SEARCHING RESOURCES FOR BIOLOGICALS, DRUGS AND OFF LABEL USE BY AHRQ. 131 -- APPENDIX 3. DATABASES SEARCHED BY AHRQ. 135 -- APPENDIX 4. ADAPTED LIST OF SOURCES FOR IDENTIFICATION 136 -- APPENDIX 5. EXAMPLE FOR AUTOMATION OF IDENTIFICATION PROCESSES 138 -- APPENDIX 6. QUESTIONNAIRE FOR IDENTIFICATION AID (ADAPTED FROM AHRQ) 138 -- APPENDIX 7. EXAMPLE OF A DATA COLLECTION FORM (SOURCE: NIHR HSRIC) 139 -- APPENDIX 8. PARAMETERS TO INCLUDE IN THE DATABASE 144 -- APPENDIX 9. DATA COLLECTION FORM 146 -- APPENDIX 10. COMPARISON OF DATA COLLECTED BY COMPANY 151 -- APPENDIX 11. EVALUATION FORMS 155 -- APPENDIX 11.1. STAKEHOLDER’S EVALUATION FORM 155 -- APPENDIX 11.2. EXPERTS INPUT EVALUATION FORM 157 -- REFERENCES 159 Link for e-copy: https://doi.org/10.57598/R283C Format of e-copy: PDF (2,1 Mb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4156 Copies(0)
Status No copy Horizon scanning for pharmaceuticals / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
Horizon scanning for pharmaceuticals : proposal for the BeNeLuxA collaboration - Synthesis [printed text] / Isabelle Lepage-Nefkens , Author ; Karla Douw, Author ; Gertjan Mantjes, Author ; Gimon de Graaf, Author ; Roos Leroy , Author ; Irina Cleemput , Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2017 . - 17 p. : ill., ; A4. - (KCE Reports. Health Services Research (HSR); 283CS) .
ISSN : D/2017/10.273/14 : € 0,00
Study 2015-57
Languages : English (eng)
Descriptors: Classification
QV 736 Drug industry. Economics of pharmacy. Advertising
Indexation
2015-57 ; Costs and Cost Analysis ; Economics, Pharmaceutical ; Europe ; Health Policy ; Information dissemination ; International Cooperation ; Policy Making ; Program Development ; R283 ; Technology Assessment, BiomedicalContents note: KEY MESSAGES 2 -- SYNTHESIS 3 -- 1. BACKGROUND, OBJECTIVES AND SCOPE 5 -- 2. PROPOSAL FOR A JOINT HORIZON SCANNING SYSTEM 5 -- 2.1. OBJECTIVES OF THE COLLABORATIVE HSS 5 -- 2.2. ORGANIZATION OF A COLLABORATIVE HSS 6 -- 2.3. SCOPE OF THE HSS 6 -- 2.4. THE HS PROCESS 6 -- 2.5. TIME HORIZON AND OUTPUTS. 7 -- 2.6. DATABASE CONTENT AND SOURCES 8 -- 2.6.1. Active scanning 8 -- 2.6.2. Main database 8 -- 2.6.3. Company pipeline meetings 9 -- 2.7. FILTRATION 10 -- 2.8. PRIORITIZATION 10 -- 2.9. ESTABLISHMENT OF THE COLLABORATIVE SYSTEM 11 -- 2.9.1. Start-up investment 11 -- 2.9.2. Annual cost 12 -- 2.10. SUMMARY OF THE PROPOSED JOINT HSS 12 -- RECOMMENDATIONS 13 Link for e-copy: https://doi.org/10.57598/R283CS Format of e-copy: PDF (735 KB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4157 Copies(0)
Status No copy Horizon scanning des produits pharmaceutiques / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
Horizon scanning des produits pharmaceutiques : une proposition pour la collaboration BeNeLuxA – Synthèse [printed text] / Isabelle Lepage-Nefkens , Author ; Karla Douw, Author ; Gertjan Mantjes, Author ; Gimon de Graaf, Author ; Roos Leroy , Author ; Irina Cleemput , Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2017 . - 14 p. : ill., ; A4. - (KCE Reports B. Health Services Research (HSR); 283BS) .
ISSN : D/2017/10.273/13 : € 0,00
Etude 2015-57
Languages : French (fre)
Descriptors: Classification
QV 736 Drug industry. Economics of pharmacy. Advertising
Indexation
2015-57 ; Costs and Cost Analysis ; Economics, Pharmaceutical ; Europe ; Health Policy ; Information dissemination ; International Cooperation ; Policy Making ; Program Development ; R283 ; Technology Assessment, BiomedicalAbstract: À la demande de la collaboration BeNeLuxA (voir encadré ci-dessous), le Centre d’Expertise des Soins de santé (KCE) a mené une étude sur les possibilités de mettre sur pied un système d’Horizon Scanning des produits pharmaceutiques commun à la Belgique, aux Pays-Bas, au Grand-Duché de Luxembourg et à l’Autriche.
L’Horizon scanning consiste à scruter (scanning) les médicaments sur le point d’arriver sur le marché, dont l’impact – clinique ou budgétaire – sur le système de santé d’un pays pourrait être important. Un tel système peut être utile pour soutenir les politiques du médicament des pays participants et les aider à identifier les sujets sur lesquels ils pourraient collaborer plus étroitement.Contents note: PRÉFACE 1 -- MESSAGES CLÉS 2 -- SYNTHÈSE 3 -- 1. CONTEXTE, OBJECTIFS ET PORTÉE 5 -- 2. PROPOSITION POUR UN SYSTEME D’HORIZON SCANNING COMMUN 5 -- 2.1. OBJECTIFS D’UN SYSTÈME D’HORIZON SCANNING COMMUN 5 -- 2.2. ORGANISATION D’UN SYSTÈME D’HORIZON SCANNING COMMUN 6 -- 2.3. PORTÉE DU SYSTÈME D’HORIZON SCANNING (HSS) 6 -- 2.4. LE PROCESSUS D’HORIZON SCANNING 6 -- 2.5. HORIZON TEMPOREL ET RÉSULTATS 7 -- 2.6. CONTENU ET SOURCES DE LA BASE DE DONNEES 8 -- 2.6.1. Scanning actif 8 -- 2.6.2. Base de données principale 8 -- 2.6.3. Réunions avec les firmes pharmaceutiques au sujet des projets en cours 9 -- 2.7. FILTRAGE 10 -- 2.8. ÉTABLISSEMENT DES PRIORITES 10 -- 2.9. MISE EN PLACE DU SYSTEME COMMUN 11 -- 2.9.1. Investissement initial 11 -- 2.9.2. Coût annuel 12 -- 2.10. SCHEMA DU SYSTEME D’HORIZON SCANNING 12 -- RECOMMANDATIONS 14 Link for e-copy: https://doi.org/10.57598/R283BS Format of e-copy: PDF (720KB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4158 Copies(0)
Status No copy Horizon scanning voor farmaceutische producten / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
PermalinkPerceptions of Growth Monitoring and Promotion among an international panel of district medical officers. in Journal of health, population, and nutrition, 23(2005)3 ([09/01/2005])
PermalinkPredictive validity of the International Hospital Outcomes Study questionnaire / Luk Bruyneel in Journal Of Nursing Scholarship, 41(2009)2 ([06/01/2009])
Permalink